Authors
Loading...
Case report reveals limited osimertinib efficacy for leptomeningeal metastasis in metastatic lung adenocarcinoma, indicating challenges with EGFR mutations.
Liu et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: